<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04022720</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201901614</org_study_id>
    <nct_id>NCT04022720</nct_id>
  </id_info>
  <brief_title>Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration</brief_title>
  <official_title>Role of Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration of Head and Neck Surgery Patients: A Prospective Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine if the use of platelet rich fibrin (PRF) improves the rate and quality of healing
      for intraoral mucosal and epithelial soft tissue defects.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in rate of healing in intraoral mucosa and epithelium soft tissues</measure>
    <time_frame>3 months post-operatively</time_frame>
    <description>Improved healing times of PRF patients compared to control group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Mucosal Ulceration</condition>
  <arm_group>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this group will receive treatment with a PRF graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Platelet Rich Fibrin Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the observational control group will be managed at the time of the complication by standard of care methods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet Rich Fibrin Application</intervention_name>
    <description>Platelet Rich Fibrin application at first post-op visit.</description>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Three categories of patients will be included in this study:

               1. Osteoradionecrosis (ORN) or medication related osteonecrosis of the jaw (MRONJ)
                  patients who present to clinic with exposed bone and no clinical sign of
                  infection.

               2. Patients having an excisional biopsy in clinic performed under local anesthesia
                  resulting in a defect that cannot be easily repaired without compromising normal
                  anatomy or function. These situations include excisions which would result in
                  primary closure under tension or with distorted anatomy, require a local flap, or
                  require healing by secondary intention.

               3. Patients presenting to the post-operative clinic with intraoral surgical wound
                  dehiscence or an intraoral surgical wound healing by secondary intention.

                  Exclusion Criteria:

          -  Patients under 18 years of age.

          -  Patient's unable to participate in blood draw either due to medical compromise,
             inability to tolerate the procedure, or inability of the physician to successfully
             draw the blood at the time of appointment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salam Salman, MD, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salam Salman, MD, DDS</last_name>
    <phone>904-244-3901</phone>
    <email>salam.salman@jax.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stacy Smith</last_name>
    <phone>904-244-3884</phone>
    <email>stacy.smith@jax.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UF Health Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 12, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2019</study_first_posted>
  <last_update_submitted>September 27, 2019</last_update_submitted>
  <last_update_submitted_qc>September 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>platelet rich fibrin (PRF)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

